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ABSTRACT
Background: Upper gastrointestinal (UGI) malignancy is one of the major causes of cancer related death. 
Endoscopy in dyspeptic patients above 45 years, or those with alarm symptoms may detect this condition. There 
were only limited data in Indonesia about age and alarm symptoms to predict UGI malignancy. This study 
was aimed to determine the prevalence of UGI malignancy among dyspepsia patients and to develop a simple 
clinical prediction model.
Method: A cross-sectional study to 390 patients with dyspepsia underwent endoscopy in Endoscopy Unit 
of Sanglah Hospital Denpasar between July 2012 and June 2013 was conducted. Demography and alarm 
symptoms were documented. Chi-square and logistic regression test analysis were conducted to analyze variables 
associated with UGI malignancy.
Results: Twenty (5.13%) of 390 patients with dyspepsia had UGI malignancy. Of the 20 patients, 65% were 
gastric cancer and 30% were esophageal cancer. The mean age was 59 ± 12 years. Variables associated with UGI 
malignancy were weight loss (OR = 8.2), dysphagia (OR = 6.2), age > 45 years old (OR = 5.6), gastrointestinal 
bleeding (OR = 5.5), persistent vomiting (OR = 5.4), and anemia (OR = 4.9). Using a simplified rule of age > 
45 years and the presence of any alarm symptom, sensitivity was 85% and specificity was 67.57%.
Conclusions: UGI malignancy was found in 5.13% of patients with dyspepsia who underwent endoscopy. 
Simple clinical prediction model states that age above 45 years and alarm symptoms may be used as a screening 
tool to predict UGI malignancy. 
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ABSTRAK
Latar belakang: Keganasan saluran cerna bagian atas merupakan salah satu penyebab terbanyak kematian 
terkait kanker. Endoskopi pada pasien dispepsia di atas usia 45 tahun atau mereka dengan tanda bahaya dapat 
mendeteksi kondisi ini. Saat ini hanya ada sedikit data di Indonesia mengenai usia dan gejala tanda bahaya 
dalam memprediksi keganasan saluran cerna bagian atas. Penelitian ini bertujuan untuk menentukan prevalensi 
keganasan saluran cerna pada pasien dispepsia dan untuk mengembangkan contoh prediksi klinis sederhana.
Metode: Suatu penelitian potong-lintang dilakukan terhadap 390 pasien dispepsia yang menjalani prosedur 
pemeriksaan endoskopi di Unit Endoskopi Rumah Sakit Sanglah Denpasar antara bulan Juli 2012 sampai Juni 
2013. Faktor demografi dan gejala tanda bahaya didokumentasikan. Analisis Chi-square dan tes regresi logistik 
dilakukan untuk menganalisa variabel yang berhubungan dengan keganasan saluran cerna bagian atas.
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Hasil: Dua puluh (5.13%) dari 390 pasien dispepsia menderita keganasan saluran cerna bagian atas. Dari 
20 pasien, 65% dengan kanker lambung, dan 30% dengan kanker esofagus. Rerata usia adalah 59 ± 12 tahun. 
Variabel yang berhubungan dengan keganasan saluran cerna bagian atas adalah penurunan berat badan (RO 
= 8.2), disfagia (RO = 6.2), usia > 45 tahun (RO = 5.6), perdarahan saluran cerna (RO = 5.5), muntah yang 
persisten (RO = 5.4), dan anemia (RO = 0.49). Dengan menggunakan aturan prediksi sederhana usia > 45 
tahun dan adanya tanda bahaya, sensitivitas mencapai 85% dan spesifisitas mencapai 67.57%.
Simpulan: Keganasan saluran cerna bagian atas dijumpai pada 5.13% pasien dispepsia yang menjalani 
prosedur pemeriksaan endoskopi. Contoh prediksi klinis sederhana menyatakan usia di atas 45 tahun dan adanya 
tanda bahaya dapat digunakan sebagai alat penapis untuk memprediksi keganasan saluran cerna bagian atas.
Kata kunci: dispepsia, tanda bahaya, keganasan saluran cerna bagian atas, contoh prediksi klinis
INTRODUCTION
Upper gastrointestinal (UGI) malignancy has been 
estimated globally to happen in about 1.4 million 
new cases in 2008.1 Gastric cancer itself is the 
world’s second leading cause of cancer mortality.1,2 
GLOBOCAN estimates that 1.1 million cancer deaths 
occurred worldwide in 2008 is due to UGI malignancy.1 
Greater than 50% of the world’s new cases of gastric 
cancer, and greater than 70% of newly diagnosed 
esophageal cancer worldwide occur in Asian countries. 
World Health Organization South-East Asia region 
(WHO SEARO) recorded 67,000 new cases of gastric 
cancer in 2008 with 15,000 (22%) of them came from 
Indonesia. Although the incidence of gastric cancer in 
Indonesia is very low, morbidity and mortality rates of 
gastric cancer in Asia remain the highest in the world. 
Of 740,000 deaths worldwide which happened due to 
gastric cancer, 13,500 deaths occurred in Indonesia.3 
UGI malignancy frequencies are varied.4-6
Endoscopy is the standard examination to diagnose 
UGI malignancy.7 Nevertheless, a prompt endoscopy 
for every dyspeptic patient cannot be a practical 
approach because it is not cost-effective and increases 
the workload of healthcare workers.8 Therefore, 
American Gastroenterology Association (AGA) 
recommends dyspeptic patients over 55 years, or those 
with alarm features such as weight loss, dysphagia, 
gastrointestinal (GI) bleeding, anemia, or persistent 
vomiting should undergo endoscopy.9 A study stated 
that alarm symptoms increased the risk of UGI 
malignancy to 5-6-fold.10 Of these patients, more than 
80% had alarm symptoms.11,12
While there are clinical features that should alert 
clinicians to the possibility of UGI malignancy, the 
effectiveness of these alarm features are unclear.13,14 
Moreover, the majority of study was conducted 
in Europe, North America, or East Asia.6,8,10,11,14 
Conclusions from Western or East Asia studies may 
not be applicable in Indonesia as the prevalence of 
UGI diseases remarkably differs. There has been 
no study of the effectiveness of age and alarm 
features for predicting UGI cancers among dyspeptic 
patients in Indonesia. The aim of this study was to 
determine the prevalence of UGI malignancy among 
dyspepsia patients who underwent endoscopy and 
to develop a simple clinical prediction model for 
UGI malignancy.
METHOD
This study is a cross-sectional study from endoscopy 
record of patient with dyspepsia. Three hundred ninety 
patients with dyspepsia underwent UGI endoscopy in 
Endoscopy Unit of Sanglah Hospital Denpasar between 
July 2012 and June 2013. The inclusion criteria were 
all patients with dyspepsia who had agreed to undergo 
UGI tract endoscopy examination. Exclusion criteria 
were patients with age under 17 years old and patients 
with documented chronic liver disease.
The data were documented from the medical 
records and questionnaire. Data acquired consisted of 
demographic data, presenting symptoms, and alarm 
symptoms. Alarm symptoms included were weight 
loss, dysphagia, GI bleeding, anemia, and persistent 
vomiting. In addition, reports of available laboratory 
and endoscopy investigations were also obtained. 
Identified histological data on biopsies of the UGI 
mucosa were also collected.
Unintentional weight loss was defined as ≥ 10% 
loss of body weight in recent 6 months. Dysphagia 
was perception of an impediment to the normal 
passage of swallowed material. GI bleeding translated 
as any evidence of hematemesis and/ or melena. 
Persistent vomiting included if there was at least 7 
to 10 days of protracted vomiting, while anemia was 
defined as hemoglobin values lower than 10 g/dL. 
UGI malignancy was defined as any histologically 
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confirmed esophageal, gastric or duodenal cancer 
detected during endoscopy.
SPSS version 17 software was used in statistical 
analysis of this study. Age was summarized as 
mean and standard deviation (SD). Sex and each 
alarm symptoms were summarized as counts and 
percentages. Test for differences in age between 
patients with and without UGI malignancy were done 
using the independent samples T-test or the Mann-
Whitney U-test as appropriate. Test for sex and each 
alarm symptoms were performed using Chi-square or 
Fisher’s exact test as appropriate.
We estimated significant variables using bivariate 
analysis. Backward stepwise selection in a multivariate 
logistic regression was made for statistically significant 
factors. Subsequently, using an automated backward-
stepwise multivariable method, we achieved the 
final model that only comprised the predictors with a 
multivariable p < 0.05. Once the variables included in 
the model were defined, we examined the calibration 
of the model by performing Hosmer-Lemeshow 
goodness-of-fit test. Based on regression model 
findings, we decided to report diagnostic accuracy 
measures using the area under the receiver operating 
characteristic (ROC) curve or AUC and its 95% 
confidence intervals (CI). Using histology as the 
gold standard for diagnosis of UGI malignancies, we 
calculated sensitivity, specificity, positive predictive 
value (PPV), and negative predictive value (NPV) 
of risk-prediction model based on selected age 
classification model and alarm symptoms. We also 
calculated diagnostic odds ratio (OR), and their related 
95% confidence intervals for age, sex, and each of 
alarm symptoms using multivariable adjusted logistic 
regression models.
RESULTS
Between July 2012 and June 2013, 390 patients 
with dyspepsia underwent UGI endoscopy. Mean age 
of patients was 48.8 ± 14.1 years, and 228 (58.5%) 
patients were above the age of 45 years. The most 
frequent age group was between 41-50 years (25.9%). 
There were 220 (56.4%) male and 170 (43.6%) female 
patient. Of these, 318 (81.5%) patients had at least one 
alarm symptoms. GI bleeding (27.9%), weight loss 
(17.9%), and anemia (16.7%) were the commonest 
alarm symptoms found in all patients (Figure 1; Table 1).
Figure 1. Proportion of all dyspeptic patient and patients with upper gastrointestinal malignancy in this study by age group
Table 1. Demographic characteristics and distribution of alarm 
symptoms in all dyspeptic patients
Characteristics
Dyspeptic patients
without upper 
gastrointestinal 
malignancy
n (%)
with upper 
gastrointestinal 
malignancy
n (%)
Mean age 48.8 ± 14.1 59.0 ± 12.0
Age (years)
> 45 210 (56.8%) 18 (90%)
≤ 45 160 (43.2%) 2 (10%)
Sex
Male 208 (56.2%) 12 (60%)
Female 162 (43.8%) 8 (40%)
History of weight loss
Absent 313 (84.6%) 7 (35%)
Present 57 (15.4%) 13 (65%)
History of GI bleeding
Absent 274 (74.1%) 7 (35%)
Present 96 (25.9%) 13 (65%)
History of persistent 
vomiting
Absent 330 (89.2%) 14 (70%)
Present 40 (10.8%) 6 (30%)
History of dysphagia
Absent 329 (88.9%) 11 (55%)
Present 41 (11.1%) 9 (45%)
Anemia
Absent 315 (85.1%) 10 (50%)
Present 55 (14.9%) 10 (50%) 
GI: gastrointestinal
All dyspeptic patients
Dyspepsia patients with upper 
gastrointestinal malignancy
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A total of 20 UGI cancers were histologicaly 
confirmed (5.13% prevalence) with 90% occurred in 
subjects over 45 years of age. If the age of 55 had been 
taken as the optimal age for screening, 60% cases would 
have been missed. Patients with UGI malignancy were 
significantly older (mean age of 59.0 years) and more 
likely to be male (60%) (Table 1). Patients reporting 
at least one of the alarm symptoms constituted 95% of 
patients with UGI malignancies compared to 53.3% in 
patients without cancer (p < 0.001).
Table 2 shows the endoscopic and histological 
findings in the study participants. Of the 20 patients 
with cancer, 13 (65%) were diagnosed with gastric 
cancer, 6 (30%) with esophageal cancer, and 1 (5%) 
with duodenal cancer. The majority of gastric cancers 
was adenocarcinomas (61.5%) and was located in the 
antrum (38.4%). Esophageal cancers were consisted 
of three adenocarcinomas and three squamous cell 
types and were located more in the distal-third of the 
esophagus (83.3%) (Table 2).
We used bivariate analysis to determine which 
variables were suitable for multivariate analysis. Male 
was not different to female of having UGI cancers (p 
= 0.740). On the other hand, relations between age 
and each alarm symptoms with UGI malignancy were 
found. Each predictor variable (age > 45, weight loss, 
dysphagia, anemia, bleeding, and persistent vomiting) 
was significant in the bivariate analysis (Table 3). 
Multivariate analysis found that age (> 45 years), 
weight loss, dysphagia, bleeding, anemia, and 
persistent vomiting were significant predictors of 
having an upper GI malignancy (Table 4). The accuracy 
Table 2. Endoscopic and histologic findings in study population
Criteria n (%)
Upper gastrointestinal endoscopy
No malignancy 370 (94.9%)
Esophageal malignancy 6 (1.5%)
Gastric malignancy 13 (3.3%)
Duodenal malignancy 1 (0.3%)
Cancer morphology
Esophageal SCC 3 (50%)
Adenocarcinoma 3 (50%)
Gastric
Adenocarcinoma 8 (61.5%)
Signet ring cell carcinoma 3 (23.1%)
Others (GIST, MALT lymphoma) 2 (15.4%)
Duodenal
Adenocarcinoma 1 (100%)
Cancer topography
Esophageal middle-third 1 (16.7%)
Esophageal lower-third 5 (83.3%)
Gastric
Cardia 2 (15.4%)
Corpus 3 (23.1%)
Antrum 5 (38.4%)
Diffuse 3 (23.1%)
Duodenal
D1 1 (100%)
SCC: squamous cell carcinoma; GIST: gastrointestinal stromal tumor; MALT: 
mucosa-associated lymphoid tissue); D1: duodenum part 1
Table 3. Bivariate analysis of variables predict UGI malignancy
Characteristic
Dyspeptic patients without 
UGI malignancy
Dyspeptic patients with 
UGI malignancy p*
Frequency % Frequency %
Age (± SD) 48.8 ± 14.1 59.0 ± 12.0 0.002
Sex
Male 208 56.2 12 60 0.740
Female 162 43.8 8 40
History of weight loss
Absent 313 84.6 7 7 < 0.001
Present 57 15.4 13 65
History of gastrointestinal bleeding
Absent 274 74.1 7 35 < 0.001
Present 96 25.9 13 65
History of persistent vomiting
Absent 330 89.2 14 70 0.010
Present 40 10.8 6 30
History of dysphagia
Absent 329 88.9 11 55 < 0.001
Present 41 11.1 9 45
Anemia
Absent 315 85.1 10 50 < 0.001
Present 55 14.9 10 50
*p values are calculated using independent sample T-test for age and Chi-square tests for variables to compare the distribution of the variables between patient 
with and without UGI malignancy; UGI: upper gastrointestinal
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of the multivariate model was shown in Figure 2. 
The Hosmer-Lemeshow test showed p = 0.902 which 
informed that this multivariate model had a good 
calibration. ROC analysis presented AUC 0.91 (95% 
CI = 0.852-0.978) indicated that this model had good 
statistic quality.
Table 4. Multivariate analysis of variables predict upper 
gastrointestinal malignancy
Variables Coefficient p OR (95% CI)
History of weight loss 2.101 < 0.001 8.17 (2.63-25.44)
History of GI bleeding 1.712 0.006 5.54 (1.64-18.70)
Persistent vomiting 1.696 0.019 5.45 (1.32-22.50)
History of dysphagia 1.830 0.004 6.23 (1.82-21.31)
Anemia 1.585 0.011 4.88 (1.44-16.55)
Age > 45 years 1.726 0.037 5.62 (1.11-28.51)
Constant -7.141 < 0.001 0.001
GI: gastrointestinal; CI: confidence interval
Figure 2. ROC curve showing the relationship between 
sensitivity and specificity of the prediction rule for major up-
per gastrointestinal pathology. The diagonal line represents a 
model which has zero predictive value. C statistic (area under 
the ROC curve) = 0.91
Due to low specificity of first model we tried to 
specify new criteria combining age and any alarm 
symptoms (weight loss, dysphagia, GI bleeding, 
anemia, and persistent vomiting). Instead of using 
just one marker such as only age older than 45 years 
or any components of alarm symptoms implied in 
the classical criteria, we used new criteria that stated 
“age older than 45 years and any components of alarm 
symptoms”. Using this new model, 17 of 137 (12.41%) 
had an UGI malignancy (positive predictive value). 
Negative predictive value of this model was 250 of 
253 (98.81%). The sensitivity of the new model was 
85% and specificity was 67.57%. Applying these new 
criteria would have resulted in findings of 17 dyspeptic 
patients with UGI malignancy.
DISCUSSION
UGI malignancy is still remaining as major health 
problem. Existing data of every state is different. UGI 
malignancies has different prevalence, ranging from 
0.5 to 9.7% from several endoscopic studies.4,15 Study 
in United Kingdom reported prevalence of 2.0 to 
3.8%.16,17 Lower incidence reported from Hongkong 
which is 0.90%.18 Records of more than 100,000 
patients in China resulted prevalence of 4.2%.6 
Another study in Cipto Mangunkusumo Hospital 
Jakarta resulted 5.20% cases of UGI malignancy 
among dyspeptic patients.12 In this study, the result is 
5.13% UGI malignancy among 390 dyspeptic patient 
underwent endoscopy. This result is greater than most 
studies but seems to be in accordance with Cipto 
Mangunkusumo Hospital study. This may be caused 
by Sanglah Hospital which acts as regional referral 
hospital from other hospitals, also from Nusa Tenggara. 
The distribution of UGI malignancy in this study is 
gastric cancer 3.33%, esophageal cancer 1.54% and 
duodenal cancer 0.26%. The result of this study is 
higher compared to study conducted in Singapore and 
Saudi Arabia where cases found were gastric cancer 
0.47% and 0.91%, esophageal cancer 0.06% and 1.49% 
respectively. But it is still lower than center in Medan 
which showed incidence of 5.6%.19 This study shows 
similarity with other studies conducted in Indonesia. 
Study in Cikini Hospital Jakarta showed that incidence 
of gastric cancer in 2005 was 3.9%.20
Most gastric cancer in our study was located at 
antrum (38.4%). This is in accordance with other 
studies in South-East Asia.12,21 Gastric cancer is 
still antral predominant cancer in Asian countries, 
and though we did not study the association of 
Helicobacter pylori (H. pylori) with the gastric 
We applied the simplified decision rule where 
the presence of any significant predictor (age > 45 
years, weight loss, dysphagia, anemia, bleeding, 
persistent vomiting) was considered as an indication 
for endoscopy. Among patients aged more than 45 or 
those with significant predictors, 20 of 318 (6.29%) 
had an UGI malignancy (positive predictive value) 
(Table 4). Among younger patients with no significant 
predictors, 72 of 72 (100%) had no UGI malignancy 
(negative predictive value) (Table 4). The sensitivity of 
the simplified prediction rule was 100% and specificity 
was 19.5%.
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cancer in our study, carcinogenesis-promoting effect 
of H. pylori seems to be responsible for this. In a 
large prospective nested case-control study, H. pylori 
was strongly associated with distal gastric cancer.22 
Adenocarcinoma constituted most of gastric cancer in 
our study. This finding was similar with other study 
which stated that approximately 90% of gastric cancers 
were adenocarcinomas.2,5,23,24 Findings of esophageal 
cancers location in our study were also similar with 
other study conducted in Jakarta. Retrospective 
study in Jakarta found lower third part as the most 
common site of esophageal cancer, as also proved by 
our study in Bali.25 This finding probably related to 
gastroesophageal reflux disease which may turn to 
Barrett’s metaplasia and predispose to malignancy in 
such location.
The mean age of UGI malignancy in this study was 
59.0 ± 12.0 years, and 90% patients were above the age 
of 45 years. Of 20 patients with UGI malignancy, 60% 
were male and 40% were female. Due to this condition 
we used the age cut-off at 45 years at Sanglah hospital. 
This is similar to the recommendation in several 
studies.8,9,15,26 Hsu reaffirmed that the age threshold for 
screening should be set at 40-50 years in Asia.8 Syam 
also agreed 45 years as the age cut-off to underwent 
endoscopy.26 Talley suggested an age cut-off of 55 
years for Western countries and a lower threshold in 
some countries in the Asia-Pacific region.9 This higher 
incidence of UGI malignancy especially gastric cancer 
observed among men is partially explained by higher 
H. pylori infection rates in male as proved by a large, 
population-based metaanalysis.27
Dyspepsia patients with alarm signs have been 
found in 19 (95%) patients, including decrease of 
bodyweight, melena, hematemesis, anemia and 
dysphagia. Of all dyspeptic patients found, GI bleeding 
was the most common alarm sign presented (27.9%). 
This is similar with study conducted in Koja hospital 
which found GI bleeding as the most common alarm 
symptoms found.28 Maconi et al reported that among 
92 gastric cancer, 58.7% had uncomplicated dyspepsia 
and 41.3% had alarm sign.29
Alarm symptoms are accepted as an indication for 
direct endoscopy.4,9 However, the existing evidence 
does not consistently support the usefulness of alarm 
symptoms for this matter.13 Another study found that 
93% of patients had an alarm feature when diagnosis 
of UGI malignancy was established.30 In this study, 
age more than 45 years, weight loss, dysphagia, 
GI bleeding, persistent vomiting, and anemia were 
all positively associated with risk of UGI cancers. 
Of these, weight loss and dysphagia were the most 
important predictors. Male was not associated with 
higher risk of UGI malignancy. Some previous studies 
have also assessed the value of age and alarm symptoms 
in predicting risk of cancer in dyspeptic patients.6,16,30 
Large samples study in China proposed criteria that 
stated age and some components of alarm symptoms 
were valuable in diagnosing UGI malignancy.6A meta-
analysis by Fransen et al found limited diagnostic 
values including sensitivity, specificity and predictive 
values, for each individual alarm symptom.4 They 
suggested using alarm symptoms in combination with 
other factors – such as age, sex, or smoking – might 
be a better tool for selection of high-risk patients. 
Kapoor et al., built criteria that said dysphagia or 
weight loss may increase the opportunity of having 
UGI malignancy.16 Khademi et al agreed criteria that 
combine demographic factors and alarm symptoms as 
clues to do endoscopy.5
In this study, six factors were found significant as 
predictors for UGI malignancy and then developed as 
a risk-prediction model. Those factors were age more 
than 45 years, weight loss, dysphagia, GI bleeding, 
persistent vomiting, and anemia. Unfortunately 
male was not significant as predictive factor. Recent 
study showed that men did not have significantly 
higher chance of UGI cancers than women.5 The 
discriminative values of alarm symptoms were further 
supported by their independent association with 
malignancy. This was also proved by group in Taiwan 
that found weight loss, GI bleeding and dysphagia as 
predictive factors for UGI malignancy.8 Among all 
predictors in study conducted in Sanglah Hospital, 
weight loss was the strongest predictor of UGI cancers 
as implied in other study.5
Risk-prediction model in our study consisted of 
age > 45 years and alarm symptoms. Using classical 
prediction model that states recommendation of 
endoscopy in subjects older than 45 years or has any 
components of alarm symptom, yield low specificity. 
Therefore, classic premise is not a proper tool as a 
screening test for UGI malignancy. By changing the 
premise into age older than 45 years and components of 
alarm symptoms, the specificity increased. New criteria 
with better sensitivity and specificity proved to be a 
good diagnostic tool in detection of UGI malignancy. 
Hsu et al also demonstrated that age threshold of 
45 years and alarm symptom would identify almost 
all dyspeptic patients with UGI malignancy.8 These 
criteria that combine age cut-off and any components 
of alarm symptoms may be used in the future among 
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primary health care, to suspect patient who most likely 
need to be further investigated by endoscopy for any 
condition of UGI malignancy. This new criteria is cost-
effective and may save burden of cost due to improper 
selection of candidate for endoscopy.
The strengths of our study are relatively large 
sample size collected for one year, simple criteria 
added in diagnosing UGI malignancy, and the first 
study in Indonesia as far as we know that prove age 
and alarm symptoms as beneficial tool in detecting UGI 
malignancy. Limitations of the study are unavailability 
of other demographic factors and clinical parameters 
such as H. pylori infection that may relate and add 
accuracy in diagnosing UGI malignancy and no 
external validation set.
CONCLUSION
Upper gastrointestinal malignancy was found in 
small portion of dyspeptic patients. The older the 
age of patients and alarm symptoms are associated 
with the risk of upper gastrointestinal malignancy. 
Simple clinical prediction model states that older age 
and any components of alarm symptoms may be used 
as a screening tool for further endoscopy. Prediction 
strategies are cost-effective and may be useful among 
primary health care services as indications in predicting 
potential upper gastrointestinal malignancies which 
may warrant referral.
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